Published in Curr Opin HIV AIDS on July 01, 2010
Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC) (EHPOC) | NCT04793750
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87
Acute HIV-1 Infection. N Engl J Med (2011) 4.84
HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS (2011) 3.39
Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS One (2013) 2.55
HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention. PLoS Med (2012) 2.21
HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76
Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS (2012) 1.73
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev (2013) 1.56
HIV transmission. Cold Spring Harb Perspect Med (2012) 1.52
Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa. J Int AIDS Soc (2011) 1.42
Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. PLoS One (2011) 1.32
Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa. AIDS (2015) 1.16
Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions. AIDS (2013) 1.10
Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women. Curr Opin HIV AIDS (2016) 0.99
The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr (2013) 0.98
Actual and undiagnosed HIV prevalence in a community sample of men who have sex with men in Auckland, New Zealand. BMC Public Health (2012) 0.95
HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis. PLoS One (2011) 0.94
Evaluation of an empiric risk screening score to identify acute and early HIV-1 infection among MSM in Coastal Kenya. AIDS (2013) 0.94
Heterogeneity in Number and Type of Sexual Contacts in a Gay Urban Cohort. Stat Commun Infect Dis (2012) 0.94
The evolving landscape of the economics of HIV treatment and prevention. PLoS Med (2012) 0.90
Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection. J Clin Virol (2013) 0.90
Current perspectives in HIV post-exposure prophylaxis. HIV AIDS (Auckl) (2014) 0.89
The use of Nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells. PLoS One (2014) 0.89
Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay. Med Microbiol Immunol (2012) 0.87
Scaling Up HIV Testing in an Academic Emergency Department: An Integrated Testing Model with Rapid Fourth-Generation and Point-of-Care Testing. Public Health Rep (2016) 0.87
Diagnosing acute and prevalent HIV-1 infection in young African adults seeking care for fever: a systematic review and audit of current practice. Int Health (2014) 0.86
How Many HIV infections may be averted by targeting primary infection in men who have sex with men? Quantification of changes in transmission-risk behavior, using an individual-based model. J Infect Dis (2014) 0.86
Future of phylogeny in HIV prevention. J Acquir Immune Defic Syndr (2013) 0.85
Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication. EBioMedicine (2017) 0.82
HIV testing practices of South African township MSM in the era of expanded access to ART. AIDS Behav (2015) 0.81
Impact of early-stage HIV transmission on treatment as prevention. Proc Natl Acad Sci U S A (2014) 0.81
Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi. J Acquir Immune Defic Syndr (2016) 0.79
Ten Years of Screening and Testing for Acute HIV Infection in North Carolina. J Acquir Immune Defic Syndr (2016) 0.79
HIV-1 testing of young febrile adults seeking care for fever in sub-Sahara Africa. Int Health (2014) 0.79
Routine Screening for HIV Infection in Medical Care Settings: A Decade of Progress and Next Opportunities. Public Health Rep (2016) 0.78
HIV infection among people who inject drugs: the challenge of racial/ethnic disparities. Am Psychol (2013) 0.78
Clinical and public health implications of acute and early HIV detection and treatment: a scoping review. J Int AIDS Soc (2017) 0.77
Role of acute HIV infection in driving HIV transmission: implications for HIV treatment as prevention. PLoS Med (2015) 0.77
Neurobehavioral Disturbances During Acute and Early HIV Infection. Cogn Behav Neurol (2016) 0.77
Sexual partnership age-pairings and risk of HIV acquisition in rural South Africa: a population-based cohort study. AIDS (2017) 0.76
Modelling the evolution of HIV-1 virulence in response to imperfect therapy and prophylaxis. Evol Appl (2017) 0.76
Concurrency and HIV transmission network characteristics among MSM with recent HIV infection. AIDS (2016) 0.75
Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89% among men who have sex with men in Bangkok. J Int AIDS Soc (2017) 0.75
Improving ART programme retention and viral suppression are key to maximising impact of treatment as prevention - a modelling study. BMC Infect Dis (2017) 0.75
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr (2005) 15.14
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66
Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS (2006) 11.20
Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30
High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis (2007) 7.70
Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60
HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses (2001) 6.00
Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis (2008) 5.85
Relation between HIV viral load and infectiousness: a model-based analysis. Lancet (2008) 5.74
Acute human immunodeficiency virus type 1 infection. N Engl J Med (1998) 5.04
Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr (1994) 4.81
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (2001) 4.76
The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 3.75
Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS (2007) 3.72
Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS (2002) 3.22
Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV. Am J Epidemiol (1998) 3.08
How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission? AIDS (2007) 2.77
Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS (2005) 2.51
Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44
Frequent detection of acute primary HIV infection in men in Malawi. AIDS (2004) 2.43
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (2001) 2.42
Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS (2000) 2.37
Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest (2004) 2.30
Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med (2010) 2.28
HIV testing in a high-incidence population: is antibody testing alone good enough? Clin Infect Dis (2009) 2.23
Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr (2006) 2.15
Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. J Clin Microbiol (2008) 2.10
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS (2001) 2.08
No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS (2008) 2.04
Diagnosis and management of acute HIV infection. Infect Dis Clin North Am (2007) 1.91
Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. AIDS (2004) 1.82
Probability of HIV transmission during acute infection in Rakai, Uganda. AIDS Behav (2007) 1.76
Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS (2010) 1.68
Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr (2009) 1.46
The effect of pair formation and variable infectivity on the spread of an infection without recovery. Math Biosci (1998) 1.32
Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I. AIDS Behav (2009) 1.26
Sexually acquired HIV infections in the United States due to acute-phase HIV transmission: an update. AIDS (2009) 1.22
Evaluating the impact of antiretroviral therapy on HIV transmission. AIDS (2008) 1.22
Targeted testing for acute HIV infection in North Carolina. AIDS (2009) 1.14
High prevalence of symptomatic acute HIV infection in an outpatient ward in southern Mozambique: identification and follow-up. AIDS (2010) 1.14
Amplified HIV transmission during early-stage infection. J Infect Dis (2006) 1.12
Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions. J Infect Dis (2009) 1.12
Acute HIV infection - New York City, 2008. MMWR Morb Mortal Wkly Rep (2009) 1.09
Implications of increased infectivity in early-stage HIV infection. Application of a Bernoulli-process model of HIV transmission. Eval Rev (1996) 1.07
HIV transmission networks. Curr Opin HIV AIDS (2009) 1.01
Number of named partners and number of partners newly diagnosed with HIV infection identified by persons with acute versus established HIV infection. J Acquir Immune Defic Syndr (2009) 0.98
Modelling the natural history of HIV infection in individuals and its epidemiological implications. Bull Math Biol (2001) 0.86
Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS (2007) 3.72
HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS (2011) 3.39
Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. J Infect Dis (2011) 3.16
Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet (2013) 2.31
The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women. J Acquir Immune Defic Syndr (2008) 1.94
HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76
Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS (2012) 1.73
Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders. Hepatology (2006) 1.69
HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med (2012) 1.55
Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis (2013) 1.43
Generalizability and scalability of HIV 'treatment as prevention'. AIDS (2013) 1.39
Does ART prevent HIV transmission among MSM? AIDS (2012) 1.20
Cost-effectiveness of provider-based HIV partner notification in urban Malawi. Health Policy Plan (2013) 1.20
Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa. AIDS (2015) 1.16
Dynamics of alanine aminotransferase during hepatitis C virus treatment. Hepatology (2003) 1.11
Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B. Antivir Ther (2007) 1.08
The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr (2013) 0.98
Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections. J Infect Dis (2010) 0.93
Assessment of peer-based and structural strategies for increasing male participation in an antenatal setting in Lilongwe, Malawi. Afr J Reprod Health (2014) 0.92
Measuring the HIV Care Continuum Using Public Health Surveillance Data in the United States. J Acquir Immune Defic Syndr (2015) 0.91
STI patients are effective recruiters of undiagnosed cases of HIV: results of a social contact recruitment study in Malawi. J Acquir Immune Defic Syndr (2014) 0.89
Self-testing for HIV and its impact on public health. Sex Transm Dis (2014) 0.88
Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi). J Acquir Immune Defic Syndr (2017) 0.87
The HIV care cascade: simple concept, complex realization. Sex Transm Dis (2014) 0.86
Temporal trends in syphilis and gonorrhea incidences in guangdong province, china. J Infect Dis (2013) 0.86
Effect of HIV status on fertility desire and knowledge of long-acting reversible contraception of postpartum Malawian women. AIDS Care (2014) 0.83
What do mathematical models tell us about the emergence and spread of drug-resistant HIV? Curr Opin HIV AIDS (2011) 0.82
Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi. J Acquir Immune Defic Syndr (2016) 0.79
HIV partner notification: possible and essential. Sex Transm Dis (2013) 0.79
Exploring the experiences of women and health care workers in the context of PMTCT Option B Plus in Malawi. J Acquir Immune Defic Syndr (2016) 0.77
CD4 count outperforms World Health Organization clinical algorithm for point-of-care HIV diagnosis among hospitalised HIV-exposed Malawian infants. Trop Med Int Health (2014) 0.76
Sexual Partnership Patterns Among South African Adolescent Girls Enrolled in STI Preventions Trial Network 068: Measurement Challenges and Implications for HIV/STI Transmission. Sex Transm Dis (2015) 0.75
"Know Your Status": results from a novel, student-run HIV testing initiative on college campuses. AIDS Educ Prev (2014) 0.75
Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study. J Acquir Immune Defic Syndr (2017) 0.75
PMTCT Option B+ does not increase preterm birth risk and may prevent extreme prematurity: A retrospective cohort study in Malawi. J Acquir Immune Defic Syndr (2016) 0.75
Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa. AIDS (2017) 0.75